Top Companies in the Clinical Trial Imaging Market
- ICON plc
- Parexel International
- BioTel Research (Philips)
- Median Technologies
- Navitas Life Sciences
- Bioclinica (Clario)
- Resonance Health Ltd.
- Cardiovascular Imaging Technologies
- IXICO plc
- Intrinsic Imaging LLC
- Radiant Sage LLC
- VirtualScopics Inc.
- WorldCare Clinical
- Calyx (formerly Perceptive Informatics)
- Imaging Endpoints
- Prism Clinical Imaging
- Synarc Imaging (merged into Clario)
- Invicro (Konica Minolta)
- RadMD
- ERT (merged into Clario)
Market Forecast
The global clinical trial imaging market size touched US$ 2.41 billion in 2024, with expectations of climbing to US$ 2.62 billion in 2025 and hitting US$ 5.58 billion by 2034, driven by a CAGR of 8.8% over the forecast period.
What are the Key trends in the Clinical Trial Imaging Market in 2024?
Advancements in Imaging Technologies – Innovations like PET/MRI, high-resolution CT, and molecular imaging improve accuracy, reduce invasive procedures, and provide real-time insights
- In March 2025, Bioclinica, now part of Clario, introduced a cloud-based image repository system to simplify storage, access, and sharing of imaging data for global clinical trials.
Collaborations Between Pharma and Imaging Providers – Partnerships with CROs and imaging solution companies provide access to expertise, infrastructure, and efficient trial workflows.
- In November 2024, ICON plc partnered with a Korean imaging AI company to improve automated tumor segmentation capabilities for oncology clinical trials.
Clinical Trial Imaging Market Value Chain Analysis
- Regulatory Approvals- Regulatory approval for clinical trial imaging mandates compliance with guidelines from authorities such as the FDA in the U.S. and the CDSCO in India. This includes following standardized protocols, ensuring high-quality data, and validating imaging systems to meet required accuracy and reliability standards.
- Serialization- Serialization in clinical trial imaging involves assigning unique identifiers, such as barcodes or QR codes, to each imaging unit and its data. These identifiers are connected to a central database, enabling accurate tracking, verification, and management of imaging assets throughout the trial and clinical workflow.
- Patient Support and Services- Patient support services in clinical trial imaging focus on standardizing imaging procedures, offering clear guidance and training for trial sites, and assisting patients throughout the process to ensure both trial accuracy and participant comfort.
Latest Announcement by Industry Leaders
In May 2025, Bayer launched its Imaging Core Lab, Centafore™, providing specialized imaging solutions for clinical trials and SaMD development. Leveraging 25+ years of experience and a network of board-certified radiologists across 50+ countries, Centafore™ offers image management, processing, interpretation, and advanced analyses. Nelson Ambrogio, Bayer’s President of Radiology, stated, “Centafore™ represents a significant leap forward in enhancing clinical trial imaging and advancing new medicines."
Recent Developments in the Clinical Trial Imaging Market
- In June 2025, HOPPR raised USD 31.5 million to enhance its AI-driven medical imaging platform, highlighting strong investor confidence in advanced analytics for clinical trial applications.
- In January 2025, Medpace expanded its imaging core lab in Cincinnati, upgrading its capabilities to include advanced MRI and OCT analysis for clinical trials.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
